Patent · US Expired

Therapeutic agents

US6403641B2 · kind B2 · utility

0Cited by
4References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 1998
Grant dateJun 11, 2002
Priority date—
Expiry dateDec 16, 2018

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for the treatment of obesity in a human in need of such treatment which comprises administration to the human of a therapeutically effective amount of a compound of formula I including enantiomers and pharmaceutically acceptable salts thereof, in which R1 and R2 are independently H or methyl, and a therapeutically effective amount of a compound of formula II wherein the compound of formula I and the compound of formula II are administered simultaneously, separately or sequentially.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.